RxDoctor Payments Data

Arash Kardan, MD

Nuclear Radiology · Houston, TXNPI 1093841777

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (45.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Telix Pharmaceuticals at 34.1% of the total.

$11,820in general payments, 2019–2025

Across 94 payments — averaging $125.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Telix Pharmaceuticals$4K
  • GE HealthCare$4K
  • Sirtex Medical Inc$2K
  • Boston Scientific$565
  • Trisalus Life Sciences, Inc.$390
  • Astellas Pharma US Inc$227
  • plus $583 from 7 others
$422,724in research payments, 2019–2025

Across 38 payments — averaging $11,124 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Blue Earth Diagnostics$266K
  • Navidea Biopharmaceuticals, Inc.$153K
  • Cardinal Health 414 LLC$3K

What the payments were for

  • Consulting fees$1,27811%
  • Speaking & faculty fees$2,63922%
  • Travel & lodging$2,31420%
  • Food & beverage$5,39946%
  • Education$1902%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,820 in reported general payments places this provider in the 75th percentile of 20 nuclear radiology providers in Texas.

See all nuclear radiology providers in Texas

Medicare billing

Part B allowed, 2024
$8,534
Medicare patients
103
Services billed
124

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nuclear radiology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →